Rhinovirus Infection – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Rhinovirus infections are typically mild and non-life-threatening, often causing a common cold. Rhinovirus infections are recurrent, with individuals experiencing multiple episodes in a year due to the existence of over a hundred different serotypes and the development of type-specific immunity. Symptoms of rhinovirus infections can vary among individuals, including nasal congestion, runny nose, sneezing, coughing, and a sore throat. Fever and general discomfort are less common than infections caused by other respiratory viruses. Children, in particular, may experience gastrointestinal issues due to rhinovirus infections. The transmission of rhinovirus primarily occurs through close contact, often via hand-to-eye or hand-to-nose contact, as well as through droplets in the air. Children play a significant role in spreading these infections within households. Once the virus reaches the nasal cavity, nearly all susceptible individuals exposed to it become infected, with 75-80% of them developing symptoms within 1 to 4 days. Furthermore, rhinovirus infections may contribute to the spread of bacteria like community-acquired methicillin-resistant Staphylococcus aureus (MRSA), particularly among children.
- In the USA, adults experience an average of 0.74 to 0.77 rhinovirus infections per person yearly.
Thelansis’s “Rhinovirus Infection Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Rhinovirus Infection treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Rhinovirus Infection across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Rhinovirus Infection Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment